Testosterone and dihydrotestosterone, or DHT, are related androgens, but DHT has a more direct role in the follicle miniaturization associated with androgenetic alopecia. DHT is produced from testosterone by the enzyme 5-alpha reductase and binds strongly to androgen receptors in susceptible scalp follicles.
This does not mean testosterone is irrelevant. Testosterone supplies the raw material for DHT production and can also activate androgen receptors. The effect on hair depends on hormone exposure, local conversion, genetics, and the biological response of each follicle.
What Is Testosterone?
Testosterone is an androgen produced primarily in the testes and, in smaller amounts, by the ovaries and adrenal glands. It contributes to sexual development, muscle and bone health, red blood cell production, libido, fertility, and other functions.
Most testosterone in the bloodstream is bound to proteins. Only a fraction is free or readily available to tissues. Blood tests may therefore measure total testosterone, free testosterone, or both depending on the clinical question.
Testosterone does not circulate only to the scalp. It acts across many tissues, and each tissue has its own enzymes and receptors that shape the response.
What Is DHT?
DHT is a metabolite of testosterone. The 5-alpha reductase enzyme converts testosterone into DHT in tissues including the skin, hair follicles, prostate, and liver.
DHT cannot be converted into estrogen and generally creates a stronger androgen-receptor signal than testosterone in certain tissues. It is important in fetal male sexual development, prostate biology, body and facial hair development, and androgenetic alopecia.
DHT is not inherently harmful. It performs normal biological functions, but genetically susceptible scalp follicles may respond to it with progressive miniaturization.
How Testosterone Becomes DHT
There are multiple forms of 5-alpha reductase, with type 1 and type 2 being most relevant to common discussions about skin and hair. Their distribution varies across tissues.
The amount of DHT acting around a follicle depends on more than serum testosterone. It is influenced by:
- Local 5-alpha-reductase activity
- Circulating androgen availability
- Androgen-receptor expression
- Enzymes that metabolize or inactivate androgens
- The follicle’s genetic sensitivity
- The anatomical region of the follicle
A person can therefore have normal testosterone but active DHT signaling in susceptible scalp follicles.
Which Hormone Causes Pattern Hair Loss?
DHT is considered the principal androgen involved in male androgenetic alopecia. It binds to androgen receptors within susceptible follicles and changes signaling from the dermal papilla, eventually shortening the growth phase and reducing follicle size.
The process is not caused by DHT alone. Androgenetic alopecia requires an inherited or acquired pattern of follicle susceptibility. Without that susceptibility, even substantial androgen exposure may not produce the classic pattern.
Testosterone can still matter because it is converted into DHT. Higher testosterone exposure may provide more substrate for conversion, although the relationship is not linear or predictable from one blood test.
Does High Testosterone Mean You Will Go Bald?
No. High testosterone does not guarantee hair loss, and low-normal testosterone does not guarantee protection.
Many men with dense scalp hair have normal or high-normal androgen levels. Many men with androgenetic alopecia have hormone results within ordinary laboratory ranges.
The common belief that baldness proves unusually high testosterone is therefore misleading. Pattern hair loss reflects follicle sensitivity at least as much as circulating hormone concentration.
DHT and the Hair-Growth Paradox
DHT can promote terminal hair growth in androgen-dependent areas such as the beard, chest, and parts of the body. In genetically susceptible scalp regions, the same broad androgen pathway may cause miniaturization.
This apparent contradiction occurs because follicles from different body sites have different local programming. Their dermal papilla cells produce different signals after androgen-receptor activation.
The hormone is the message, but each follicle type interprets that message differently.
How DHT Changes Susceptible Scalp Follicles
DHT-related miniaturization develops across repeated hair cycles. The active growth phase becomes shorter, and newly produced hairs become progressively thinner and shorter.
Early in the process, the scalp may look less dense even though many follicles remain present. Later, severely miniaturized hairs may become difficult to see.
This gradual progression creates an opportunity for treatment while follicles are still viable. Completely bare, long-standing areas are less likely to show substantial medical regrowth.
Do Testosterone Treatments Increase Hair-Loss Risk?
Testosterone replacement therapy may accelerate androgenetic alopecia in a genetically susceptible person, even when treatment is medically appropriate. Nonmedical bodybuilding doses and anabolic steroid cycles can create greater and less predictable androgen exposure.
Not everyone using testosterone will lose scalp hair. Risk depends on baseline miniaturization, genetics, dose, resulting hormone levels, other compounds, and duration of exposure.
Prescribed testosterone should not be stopped or altered without consulting the clinician managing it. Hair concerns need to be balanced against the medical reason for treatment.
How Finasteride Changes the Balance
Finasteride inhibits type 2 5-alpha reductase, reducing the conversion of testosterone to DHT. It can substantially lower scalp and serum DHT while leaving testosterone intact or producing a small increase within the physiological range.
This explains why finasteride is not the same as blocking all androgens. It changes one conversion pathway rather than eliminating testosterone.
Dutasteride inhibits both type 1 and type 2 5-alpha reductase and generally suppresses DHT more strongly. Its approval for hair loss varies by country, and greater DHT suppression does not remove the need to consider adverse effects.
Can Testosterone Alone Affect Hair Follicles?
Testosterone can activate androgen receptors, although DHT produces a stronger signal in many relevant tissues. In people with 5-alpha-reductase deficiency, the usual development of certain androgen-dependent features, including substantial beard growth and typical male pattern baldness, is reduced. This supports DHT’s central role.
Hair biology is still more complex than a two-hormone comparison. Receptor regulation, inflammation, growth factors, local enzymes, and the hair cycle all influence the visible outcome.
Should Testosterone and DHT Be Tested for Hair Loss?
Classic male pattern hair loss is usually diagnosed from its distribution and follicle miniaturization rather than hormone testing. A normal result does not exclude it.
Testing becomes more relevant when hair loss occurs with signs of an endocrine disorder. In women, these may include irregular periods, severe acne, increased facial hair, fertility concerns, or rapid-onset pattern thinning. In men, symptoms of androgen deficiency or excess may also justify evaluation.
Tests should answer a defined clinical question rather than serve as a general baldness score.
Frequently Asked Questions
Is DHT stronger than testosterone?
DHT binds more strongly to androgen receptors and produces a more potent signal in several tissues. Testosterone has broader roles and can also be converted into estrogen.
Does all testosterone become DHT?
No. Only a portion is converted through 5-alpha reductase. Testosterone also remains unchanged or enters other metabolic pathways.
Can high DHT occur with normal testosterone?
Yes. Local enzyme activity and individual metabolism can influence DHT production, and tissue exposure may differ from blood measurements.
Is testosterone responsible for beard growth?
Testosterone contributes, but conversion to DHT and local follicle sensitivity are important for full terminal beard development.
Does reducing DHT lower testosterone?
Finasteride usually does not lower testosterone. By reducing conversion to DHT, it may cause a modest increase in circulating testosterone in some users.
Is DHT the only cause of hair loss?
No. DHT is central to androgenetic alopecia, but many other conditions cause shedding, breakage, inflammation, or scarring through unrelated mechanisms.
The Practical Difference
Testosterone is a major circulating androgen with broad functions throughout the body. DHT is a more potent local androgen produced from testosterone and has a particularly important role in miniaturizing genetically susceptible scalp follicles.
Neither hormone level alone predicts who will lose hair. The clinically relevant issue is the interaction between androgen exposure and the individual follicle’s sensitivity.
This content is for general informational purposes and does not replace individualized medical advice, diagnosis, or treatment.
